Evaluating the Use and Impact of Telemedicine Among Latina Women of Reproductive Age with Type II Diabetes
Evaluating the Use and Impact of Telemedicine Among Latina Women of Reproductive Age with Type II Diabetes
批准号:
10770769
负责人:
Jorge Rodriguez
金额:
$14.9万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-08 至 2026-05-31
关键词:
AddressAffectAgeAlgorithmsBig DataBiologicalBiometryCaringClinicClinicalClinical InformaticsClinical TrialsCollaborationsComplementDataData AnalyticsData SourcesDiabetes MellitusDiseaseDisparityElectronic Health RecordEnsureEthnic OriginFemaleGoalsGrantGynecologicHealthHealth SciencesHealth Services AccessibilityHealth Services ResearchInequityInfant HealthInterdisciplinary StudyInterruptionLatinaLatinoLatino PopulationLinguisticsLong-Term CareMachine LearningMaternal HealthMentorshipModelingNeighborhoodsNon-Insulin-Dependent Diabetes MellitusOutcomePatientsPopulationPrevalenceRaceResearchResearch MethodologySeriesStrategic PlanningSubgroupTelemedicineTelephoneTestingTrainingUnited States National Institutes of HealthWomanWomen&aposs HealthWorkaccess disparitiesclinical applicationcohortcommunity engagementcomparison controldata sharingexperiencefollow-upglycemic controlhealth information technologyhealth service useimplementation interventionimplementation strategyimprovedimproved outcomeinnovationmachine learning methodmaternal outcomeneonatal outcomenovelpandemic diseaseparent grantpoor health outcomepreventremote visitreproductiveskillssocialsocial factorsstatistical and machine learningunsupervised learninguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Latina women of reproductive age are disproportionately affected by type II diabetes. From 1996 to 2014, Latina women
experienced a 125.2% increase in age-adjusted prevalence of pregestational type II diabetes compared to only 13.6% for
non-Latina White women. Women with pregestational diabetes experience worse maternal and neonatal outcomes.
This is driven by biological, cultural, and social factors, including, including access to care. Preventing maternal and infant
health complications requires close follow-up in the pregestational period. By extending care beyond the clinic,
telemedicine presents an opportunity to address these challenges. Telemedicine offers patients video and telephone
visits from remote settings. It presents an opportunity to increase access to care and potentially improve care for Latina
women of reproductive age with type II diabetes. The goal of this supplement to my K23 parent grant is to address this
critical need by to evaluating the uptake, use, and impact telemedicine on diabetes outcomes for Latina women of
reproductive age with type II diabetes. My central hypothesis is that by applying rigorous and innovative statistical and
machine learning approaches we can identify disparities in access to telemedicine among Latina women of reproductive
age with type II diabetes and assess the impact of telemedicine on diabetes outcomes. The proposed project will test the
central hypothesis with the following 3 specific aims. Aim 1 will examine the access and use of telemedicine among
Latina women of reproductive age with type II diabetes. Aim 2 will assess the impact of telemedicine on glycemic control
among Latina women of reproductive age with type II diabetes. Aim 3 will utilize an unsupervised machine learning
approach to detect latent subgroups based on patient demographic, clinical, and social factors and then evaluate their
clinical applications in telemedicine use. Through the application of advanced biostatistical and machine learning
methods supported by community engagement, this proposal addresses overlapping health information technology and
diabetes disparities among Latina patients of reproductive age with type II diabetes.
The proposed research is complemented by a rigorous training plan and a highly experienced mentorship and
collaboration team that will ensure my completion of this supplement. The training plan focuses on biostatistical
research methods, machine learning, and mentorship skills. This proposal will further support my K23 which forms the
basis for an R01 application centering on a larger clinical trial testing the effect of the implementation intervention on
clinical outcomes among Latino patients with diabetes.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Persistence of Unequal Access to Classical Hematology Telemedicine Visits by Race and Other Demographics During the COVID-19 Pandemic.
COVID-19 大流行期间,按种族和其他人口统计数据来看,经典血液学远程医疗就诊的机会持续存在不平等。
DOI:
10.1089/tmj.2022.0505
发表时间:
2023
期刊:
Telemedicine journal and e-health : the official journal of the American Telemedicine Association
影响因子:
--
作者:
[Osei,MiriamA, Merz,LaurenE, Ren,Siyang, Neuberg,DonnaS, Achebe,Maureen, Rodriguez,JorgeA, Langer,ArielleL]
通讯作者:
Langer,ArielleL
A Research Agenda for Using Machine Translation in Clinical Medicine.
在临床医学中使用机器翻译的研究议程。
DOI:
10.1007/s11606-021-07164-y
发表时间:
2022
期刊:
Journal of general internal medicine
影响因子:
5.7
作者:
[Khoong,ElaineC, Rodriguez,JorgeA]
通讯作者:
Rodriguez,JorgeA
Leveraging large language models to foster equity in healthcare.
利用大型语言模型促进医疗保健公平。
DOI:
10.1093/jamia/ocae055
发表时间:
2024
期刊:
Journal of the American Medical Informatics Association : JAMIA
影响因子:
--
作者:
[Rodriguez,JorgeA, Alsentzer,Emily, Bates,DavidW]
通讯作者:
Bates,DavidW
DOI:
10.1038/s41746-023-00954-0
发表时间:
2023-11-02
期刊:
NPJ digital medicine
影响因子:
15.2
作者:
[]
通讯作者:
What Does a New Health Technology Landscape Mean for Hispanic/Latino People With Diabetes?
新的健康技术格局对西班牙裔/拉丁裔糖尿病患者意味着什么?
DOI:
10.2337/cd22-0087
发表时间:
2023
期刊:
Clinical diabetes : a publication of the American Diabetes Association
影响因子:
--
作者:
[Rodriguez,JorgeA, Seiglie,JacquelineAnne, Caballero,AugustoEnrique]
通讯作者:
Caballero,AugustoEnrique
共 6 条
Toward Technology Equity: Extending Telemedicine to Latino Patients with Type II Diabetes
-
批准号:10283266
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2021
-
负责人:Jorge Rodriguez
-
依托单位:
Toward Technology Equity: Extending Telemedicine to Latino Patients with Type II Diabetes
-
批准号:10630870
-
项目类别:
-
资助金额:$16.74万
-
财政年份:2021
-
负责人:Jorge Rodriguez
-
依托单位:
海外基金